Last update March 19, 2020
Very Low Risk
Topical dermatological and gynecological antiseptic. Also used in oral rinses and for the treatment of canker sores and as a hemostatic in hemorrhoids.
Since the last update we have not found published data on its excretion in breastmilk.
The small dose and the low plasma absorption of most topical dermatological and gynecological preparations make transfer into breastmilk in significant amounts unlikely.
In the case of policresulen, the manufacturer assures that there is no systemic absorption and that it is compatible with breastfeeding (Takeda 2018, CecMed 2018).
When used orally, it must be taken in a highly diluted form followed by rinsing within a few minutes to avoid local irritation and burns (Wardhany 2016).
There is very little literature on this product and/or it is not up to date.
We do not have alternatives for Policresulen since it is relatively safe.
Suggestions made at e-lactancia are done by APILAM team of health professionals, and are based on updated scientific publications. It is not intended to replace the relationship you have with your doctor but to compound it. The pharmaceutical industry contraindicates breastfeeding, mistakenly and without scientific reasons, in most of the drug data sheets.
Your contribution is essential for this service to continue to exist. We need the generosity of people like you who believe in the benefits of breastfeeding.
Thank you for helping to protect and promote breastfeeding.
e-lactancia is a resource recommended by Academy of Breastfeeding Medicine - 2012 of United States of America
Would you like to recommend the use of e-lactancia? Write to us at corporate mail of APILAM